Home/Investors/Angel investors Angel investors
Biotech Investor · 18 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| SDIP Innovations | preclinical | — | Orthopedics, Bone Regeneration |
| MyoGene Bio | Pre-clinical | — | Muscular Disorders, Rare Disease |
| NERx Biosciences | Pre-clinical | — | Oncology |
| Indi Molecular | Pre-clinical | — | Oncology |
| OmniCyte | Pre-clinical | — | Oncology |
| Eventum Orthopaedics | Commercial | — | Orthopaedics, Musculoskeletal |
| Manzanita Pharmaceuticals | Pre-clinical | — | Oncology, Neurology |
| Metri Bio | Pre-clinical | — | Endometriosis, Women's Health |
| Kyron.bio | Pre-clinical | — | Oncology, Autoimmune Diseases |
| Alderley Analytical | Commercial | — | — |
| Trethera | Phase 1 | — | Oncology, Autoimmune Diseases |
| Biomendics | Phase 2 | — | Rare Dermatologic Disorders |
| Phaim Pharma | Phase 1 | — | Autoimmune Diseases, Type 1 Diabetes |
| ReVivo Medical | Phase 1 | — | Spinal Disorders, Orthopedics |
| AmXpress | platform | — | Platform Technology |
| Taron Solutions | platform | — | CNS, Infectious Disease |
| Northernmost | preclinical | — | Kidney Transplantation |
| Vesalic | preclinical | — | Oncology |